In May 2024, Neuralink moved closer to its ambitious goal of creating a brain-computer chip bridge. Despite facing animal rights violation charges, it received FDA approval for human trials after 294 tests on pigs, sheep, and primates. Noland Aubargh, a 29 -year-male volunteering for the N1 human trials last September, is showing overwhelming results as the engineer engaged in the experiment himself shared a video of Aubargh on 30th Jan where Nolan said, Neuralink reports no cognitive impairments in the subject since the implant, stating that the subject can control devices with their brain. Paul Nuyujukian, a professor of bioengineering…